BYDUREON BCISE FDA approval date
The FDA approved BYDUREON BCISE on 20 Oct 2017.
- FDA approval date
- 20 Oct 2017
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as EXENATIDE SYNTHETIC
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2017-10-20Day | BYDUREON BCISE | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209210", "applicant_as_listed_by_fda": "ASTRAZENECA AB", "brand_names": ["BYDUREON BCISE"], "active_ingredients": ["EXENATIDE SYNTHETIC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20171020", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |